<h4>Background</h4>Although the mucin glycoprotein <i>MUC16</i> is well established as an oncogenic biomarker in ovarian cancer, its mechanistic contribution to lung adenocarcinoma (LUAD) remains poorly defined. This evidence concerns the gene MUC16 and lung adenocarcinoma.